Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study

• Glavni autori: Remon Abu-Elyazeed (Autor), William Jennings (Autor), Randall Severance (Autor), Michael Noss (Autor), Adrian Caplanusi (Autor), Michael Povey (Autor), Ouzama Henry (Autor)
• Format: Knjiga
• Izdano: Taylor & Francis Group, 2018-11-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

The introduction of vaccination programs against measles, mumps, and rubella (MMR) led to significant global reduction in morbidity and mortality from these diseases. The currently recommended MMR vaccination schedule in the United States of America comprises 2 vaccine doses typically administered a...